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Abstract
Background: Although rare, serum sickness-like reactions have been documented to occur
following the administration of many antibiotics. Cefazolin, a first generation cephalosporin, is a
commonly prescribed antibiotic which is considered to be generally safe and well tolerated. There
have been no prior reports linking this drug with sickness-like reactions. We report a probable case
of serum sickness-like reaction following a single dose of cefazolin.
Case Presentation: A 23 year old man with no significant past medical history was admitted to
undergo a laparoscopic donor nephrectomy as part of a living-related renal transplant. One gram
of intravenous cefazolin was administered perioperatively. The surgery was completed without
complication and the remainder of his hospital course was uneventful. Ten days following discharge
the patient developed fevers, painful and swollen joints, and a cutaneous eruption overlying his
trunk and extremities. There was no evidence of systemic vasculitis. These clinical findings were
most consistent with a serum sickness-like reaction. A brief course of corticosteroids and
antihistaminergic therapy was initiated, and complete resolution of the patient's symptoms
followed. The Naranjo probability scale indicated that this adverse drug event was probable.
Conclusion: Serum sickness-like reaction may be associated with cefazolin therapy.
Background
Serum sickness-like reactions (SSLR), although rare in
clinical practice, have been documented to occur follow-
ing the administration of many medications. While the
pathophysiology which produces SSLR are not clear, they
are constituted by an array of clinical findings including
fever, cutaneous eruptions and arthralgias/arthritis. Liter-
ature reports have implicated several antibiotics including
ciprofloxacin [1,2], minocycline[3], cefprozil[4], and
cefaclor [5-7]. Herein, we report a probable case of SSLR
following a single dose of cefazolin.
Case Presentation
The patient, a 23 year old male with no significant past
medical history, underwent left laparoscopic donor
nephrectomy as part of a living-related renal transplant.
On the day of surgery he was administered one gram of
intravenous cefazolin which served as routine periopera-
tive prophylaxis. Anesthesia was achieved with inhaled
desflurane, along with fentanyl, propofol, and mida-
zolam. Cisatracurium was employed for neuromuscular
blockade. Post operatively, he received morphine sulfate,
ketorolac, and ondansetron. His recovery was uneventful,
and he was discharged home three days after his surgery
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with prescriptions for docusate sodium, acetaminophen,
and hydrocodone. Upon discharge his serum creatinine
was 1.8 mg/dL, WBC 10.0 per 109/L, platelet count 197
per 109/L, hemoglobin 13.4 g/dL. Eosinophils constituted
0.2% of WBC population.
Post operative day ten was marked by the emergence of
fevers as high as 38.4 C, generalized weakness, and
arthralgias involving bilateral knees, wrists, ankles, and
metacarpophalangeal (MCP) joints. Simultaneously, a
cutaneous eruption appeared which was initially limited
to bilateral upper extremities but soon involved his trunk,
back, face and lower extremities. Furthermore, additional
MCP joints become swollen and tender in sequential
order from medial to lateral. Upon questioning, he
denied the presence of any gastrointestinal disturbance
such as nausea, emesis, or diarrhea. On physical examina-
tion he was found to be afebrile. He appeared uncomfort-
able but was in no apparent distress. Oropharyngeal,
pulmonary, and cardiac examinations were unremarka-
ble. Although there was mild peri-incisional tenderness,
his abdomen was soft and his surgical wounds appeared
to be healing well with no evidence of local infection.
There was no lymphadenopathy. Diffuse urticaria involv-
ing all extremities, trunk, back, neck, and face were noted.
Nearly all his MCP joints were warm, swollen, and tender
to touch. Of note, there appeared to be a sequential pat-
tern of early MCP joint resolution as the medial joints that
had been initially affected most, now appeared to be
improving somewhat while the lateral ones were now
most affected. In addition, the knees, ankles, wrists, and
left metatarsophalangeal joint were also affected,
although no effusions were appreciated upon physical
examination. Repeat laboratory analysis was performed
which revealed serum creatinine was 1.6 mg/dL, WBC 9.7
per 109/L, platelet count 353 per 109/L, hemoglobin 13.8
g/dL. Eosinophils constituted 2.6% of WBC population.
Serum complement levels, immunoglobulin concentra-
tions, and erythrocyte sedimentations rate were not
obtained at this time. Urinalysis revealed trace albuminu-
ria, with no hematuria or glycosuria. Microscopic exami-
nation of the urine revealed rare hyaline casts and the
distinct absence of red or white cells and cellular casts.
Based on the aforementioned clinical findings, the
absence of systemic vasculitis, and a history of a cepha-
losporin antibiotic exposure approximately two weeks
earlier, a diagnosis of a SSLR was made. For five days, he
was treated with prednisone 20 mg twice daily, loratadine
10 mg daily as well as famotidine 20 mg twice daily for H2
receptor blockade. Within 48 hours he noted near resolu-
tion of the urticaria as well as a significant improvement
in the inflamed joints. He was reevaluated two weeks after
this treatment and was found to have no further evidence
of fevers, rash, or joint involvement. Antinuclear antibod-
ies by enzyme immunoassay were not detected, serum
complement levels were within the normal ranges for our
laboratory as was serum IgE levels which were measured
at 36.8 IU/mL.
Discussion
Serum sickness-like reactions have been noted to occur in
response to a variety of drugs, a majority of them being
antibiotics[5]. Manifestations often include fever, rash,
and joint inflammation, but generally lack generalized
lymphadenopathy and evidence of systemic vasculitis
such as glomerulonephritis [8]. Accordingly, the levels of
circulating immune complexes and serum complement
are often unaffected[5].
While the underlying pathophysiology remains unclear,
SSLR continues to be documented as an adverse event for
a small but growing number of drugs. To date there have
been no published reports of serum sickness or SSLR fol-
lowing cefazolin administration. Although our patient
did receive various other medications, only cefazolin
belongs to a drug class which has repeatedly been impli-
cated as a cause for SSLR. In the case just described, the
Naranjo probability scale for adverse drug reactions indi-
cates that cefazolin was the probable cause of SSLR[9].
Conclusion
Several drugs have been connected to the development of
SSLR including cephalosporin antibiotics such as cefaclor
and cefprozil. We now report a probable case of SSLR in
connection with cefazolin. Accordingly, we urge clinicians
need to be aware of SSLR as a potential complication to
this common therapy.
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